Microfluidics Research Engineer Kenneth J. Chomistek To Speak At The ISPE 2008 Annual Meeting

Newton, Mass.— October 10, 2008 — Microfluidics research engineer Kenneth J. Chomistek will be presenting a talk titled “Microfluidizer®  Processors: Creating Pharmaceutical Nanoparticles” on Wednesday October 29, 2008 at 2:30 pm at the ISPE 2008 Annual Meeting in Boca Raton, Fla.

Mr. Chomistek is a research engineer in the Microfluidics Technology Center.  Microfluidics is a wholly owned subsidiary of Microfluidics International Corporation (OTCBB: MFLU). He is currently working with the development of Microfluidics Reaction Technology (MRT), an award-winning process intensification technology used to manufacture nanosuspensions for pharmaceutical and biotechnology applications. Prior to working at Microfluidics, Mr. Chomistek was a research engineer with Network Biosystems, a spin-off from the Whitehead Institute, a leading independent nonprofit research and educational institution that shares a teaching affiliation with Massachusetts Institute of Technology (MIT).  In this previous position, he was involved in the design, modeling and fabrication of microfluidics systems used for integrated chemical and biological analysis using thermal-casted polymers.

Mr. Chomistek holds a B.S. and M.S. in Chemical Engineering from the University of Michigan. He has co-authored multiple papers for journals and conference proceedings.

Microfluidics offers a complete line of ultra high-shear Microfluidizer processors for drug delivery applications. Recent advances in high throughput screening and drug discovery have led to new chemical compounds being identified as potential drug candidates.  By enabling the creation of nanosuspensions, the expertly-engineered Microfluidizer processors overcome the challenges of poor water and oil-based solubility posed by chemical components.  The ultra high-shear created by the Microfluidizer processors reduces the particle size of active pharmaceutical ingredients to nanoparticles, which is critical to the creation of suspensions of solid materials. Another benefit is that the Microfluidizer processors create a stable product with a longer shelf life. Also, uniformly small particles can enable formulations to be filter-sterilized.

Additional applications for Microfluidics technology include biotechnology, personal care, chemicals, electrode materials for batteries and fuel cells, food and beverage nutraceuticals, nanoceramics for optical coatings and carbon nanotube dispersion.

About Microfluidics

Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available. Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or contact Microfluidics at 800.370.5452 for application information.